The Value of Human Milk in the NICU: Reducing Morbidities & Necrotizing Enterocolitis

Recently, the Joint Commission joined professional organizations, the CDC and the US Surgeon General, in publically promoting the benefits of human milk for all infants, including preterm infants. The evidence supporting the use of human milk in the NICU is both extensive and compelling: laboratory and clinical research demonstrate the value of human milk in reducing multiple disease states of the preterm infant including necrotizing enterocolitis, chronic lung disease, retinopathy of prematurity, and infections. Against this backdrop of information and data, it is easy to lose sight of the most critical and consistent element in all of these diseases: the interface of human milk with the infant gastrointestinal system.

Learn more about The Value of Human Milk in the NICU.
Read the Innovating Practice research overview and summaries now

  • Intestinal Permeability in Preterm Infants by Feeding Type: Mother's Milk Versus Formula - journal article

  • Role of Human Milk in Extremely Low Birth Weight Infants' Risk of Necrotizing Enterocolitis or Death - journal article

  • An Exclusively Human Milk-Based Diet is Associated with a Lower Rate of Necrotizing Enterocolitis Than a Diet of Human Milk and Bovine Milk-Based Products (article is unavailable)

Register for the online course